Novavax, Inc. (NVAX)
Nasdaq: NVAX · Biological Products, (No Diagnostic Substances) · Gaithersburg, MD · filing with the SEC since 1996
Who owns Novavax, Inc.
As filed with the SECHolders of 5% or more
4
Blackrock, Inc. holds 8.4% of Common Stock, as its SCHEDULE 13G/A filed Feb 5, 2025 says.
Directors and officers
14
report now, of 25 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Feb 5, 2025 · Common Stock
State Street Corporation
SCHEDULE 13G · filed Aug 7, 2026 · COMMON STOCK · 5.9% in Feb 9, 2026
Himanshu H. Shah
SCHEDULE 13G · filed Oct 16, 2026 · Common Stock, Par Value $0.01 per share · 6.46% in Oct 16, 2026
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
Bank of America Corporation
SCHEDULE 13G/A · filed Apr 27, 2026 · Common Stock · reported falling below 5%, from 5.1% in Feb 11, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What NVAX reports owning in othersstakes of 5% or more, and other ties
9 subsidiaries in 9 countries, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2024 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.